• Latest Posts

Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy 

In Depth 20 Dec 2022

Ebvallo approval ushers in off-the-shelf T-cell immunotherapies

Watch: Valo Therapeutics at Bio-Europe

Watch: Mendus interview 

Sanofi and Innate Pharma expand natural killer cell deal

ImaginAb launches trial to study neoadjuvant immunotherapy

ADVERTISEMENT

Etcembly reveals breakthrough in optimizing TCR assets

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

Beyond Biotech podcast 25: Center for Global Development, Humacyte, Transgene

Touchlight and Odimma Therapeutics sign deal to develop personalized cancer therapy

Pictor receives $5M in funding for Covid antibody test and human and animal portfolios

Lyvgen and Bristol Myers Squibb commitment to transform cancer care

ADVERTISEMENT